RGT 0.00% 28.5¢ argent biopharma limited

"... deferral of non-essential research and development, and...

  1. 5,264 Posts.
    lightbulb Created with Sketch. 1642
    "... deferral of non-essential research and development, and cancelation or renegotiation of all existing contracts, as noted in recent Company announcements in February and March"

    Well, on the one hand the agreement as per TH anns with Swiss comp was "VITAL", and now, "Non essential" ... only when they were asked to substantiate the anns!!!
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.